Author:
Shabaruddin F H,Elliott R A,Valle J W,Newman W G,Payne K
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Aapro MS, Cameron DA, Pettengell R, Bohlius J, Crawford J, Ellis M, Kearney N, Lyman GH, Tjan-Heijnen VC, Walewski J, Weber DC, Zielinski C, EORTC G-CSF Guidelines Working Party (2006) EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours. Eur J Cancer 42: 2433–2453
2. Ando Y, Saka H, Ando M, Sawa T, Muro K, Ueoka H, Yokoyama A, Saitoh S, Shimokata K, Hasegawa Y (2000) Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis. Cancer Res 60: 6921–6926
3. Anonymous (2006) Invader UGT1A1 molecular assay for irinotecan toxicity. A genetic test for an increased risk of toxicity from the cancer chemotherapy drug irinotecan (Camptosar). Med Lett Drug Ther 48: 39–40
4. Antonini A, Berto P, Lopatriello S, Tamma F, Annemans L, Chambers M (2008) Cost-effectiveness of I-FP-CIT SPECT in the differential diagnosis of essential tremor and Parkinson's disease in Italy. Mov Disord 23: 2202–2209
5. Bojke L, Claxton K, Sculpher M, Palmer S (2009) Characterizing structural uncertainty in decision analytic models: a review and application of methods. Value Health 12: 739–749
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献